Clinical pharmacogenomics: patient perspectives of pharmacogenomic testing and the incidence of actionable test results in a chronic disease cohort.

导出 OA

翻译打印收藏纠错

第一作者： Chandrama,Mukherjee

第一单位： Department of Biological Chemistry & Pharmacology, Ohio State University, Columbus, OH 43210, USA.

作者： Chandrama,Mukherjee ^[1] ; Kevin M,Sweet ^[1] ; Jasmine A,Luzum ^[2] ; Mahmoud,Abdel-Rasoul ^[2] ; Michael F,Christman ^[3] ; Joseph P,Kitzmiller ^[3]

作者单位： Department of Biological Chemistry & Pharmacology, Ohio State University, Columbus, OH 43210, USA. ^[1] Division of Human Genetics, Ohio State University, Columbus, OH 43210, USA. ^[2] Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA. ^[3] Center for Biostatistics, College of Medicine, Ohio State University, 1800 Cannon Drive Columbus, OH 43210, USA. ^[4] Coriell Institute for Medical Research, Camden, NJ 08103, USA. ^[5] Center for Pharmacogenomics, College of Medicine, Ohio State University, 5086 Graves Hall, 333 West 10th Avenue Columbus, OH 43210, USA. ^[6]

关键词 actionable test results cardiovascular drugs clopidogrel patient perspectives personalized medicine pharmacogenetics pharmacogenomics precision medicine simvastatin warfarin

DOI 10.2217/pme-2017-0022

PMID 29181084

发布时间 2022-03-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交